GlassScriptPhysician profile
Jennifer Uzzell
NPI 1578701439
$1,493.29
in general payments reported to CMS, 2019-2025
15 companies · $658 in 2025
The $658 reported for 2025 was more than what 94% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.86 · 2023: $372 · 2024: $431 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $243.66 | 2024-2025 | Koselugo |
| Kyowa Kirin, INC. | $231.05 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $202.39 | 2023-2025 | Dupixent |
| Alk-Abello, INC | $185.86 | 2023-2024 | Grastek, Odactra |
| Organon LLC | $101.80 | 2025 | Vtama |
| Pharming Healthcare, INC. | $97.29 | 2023 | Joenja |
| Biogen, INC. | $96.21 | 2023 | Spinraza |
| Genentech USA, INC. | $92.23 | 2025 | Xolair |
| Cranial Technologies, INC | $45.92 | 2023-2025 | Doc Band |
| Novo Nordisk INC | $40.00 | 2023 | |
| Merck Sharp & Dohme LLC | $38.50 | 2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $37.51 | 2025 | Qelbree |
| Glaxosmithkline, LLC. | $32.86 | 2021 | |
| Sanofi Pasteur INC. | $29.61 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $18.40 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Uzzell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.